GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EBR Systems Inc (ASX:EBR) » Definitions » Insider Ownership

EBR Systems (ASX:EBR) Insider Ownership : 0.00 % (As of May. 07, 2025)


View and export this data going back to 2021. Start your Free Trial

What is EBR Systems Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, EBR Systems's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, EBR Systems's Institutional Ownership is 4.83%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, EBR Systems's Float Percentage Of Total Shares Outstanding is 75.67%.


EBR Systems Insider Ownership Historical Data

The historical data trend for EBR Systems's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EBR Systems Insider Ownership Chart

EBR Systems Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Insider Ownership
- - - -

EBR Systems Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

EBR Systems Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


EBR Systems Business Description

Traded in Other Exchanges
N/A
Address
480 Oakmead Parkway, Sunnyvale, CA, USA, 94085
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside the left ventricle of the heart. It conducts its operations in the United States.